Europe Vascular Stent Market

Europe Vascular Stent Market Size (2024 to 2032)

The size of the Vascular Stent Market in Europe was worth USD 6.23 billion in 2024 and is projected to be growing at a CAGR of 15.5%, to touch 19.72 billion by 2032, during the forecast period.

The primary function of a vascular stent is to help in keeping the clogged artery open which results in better and free blood flow to the heart. The unclogged arteries and increased blood flow substantially reduce the chances of a heart attack. A stent is an expandable and tiny mesh made of metals or polymers. An implanted stent stays in the artery permanently, although an angiography procedure can remove a blocked stent.

The growth of the Europe Vascular Stent Market is mainly driven by the increasing use of vascular stents for cardiovascular diseases. It is further supplemented by the growing preference for stents over other outdated methods which were relatively more invasive. The rising elderly populace in Europe with the consequent incidence of CVDs is also a significant promoter of market growth.

The restraints faced by the market include the stringent regulation policies by governmental bodies and incidences of product failure and recalls.

This research report on the Europe Vascular Stent Market has been segmented and sub-segmented into the following categories and analyzed market size and forecast for each segment until 2032.

• By Product: Peripheral Stents, Coronary Stents, and EVAR Stent Grafts.
• By Type: Bare-Metal Stents, Drug-Eluting Stents, and Bioabsorbable Stents.
• By Mode of Delivery: Self-Expanding Stents and Balloon Expanding Stents.
• By Material: Metal and Polymer.
• By End User: Hospitals and Research Institutes.
• By Country: UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe.

Regionally, Europe was the second leading region in the global vascular stent market in 2019. Growing usage of vascular stents for heart-related problems is the primary factor driving the European market. Further, the increasing importance of stents over the outdated methods which were relatively more invasive accelerating the vascular stent market growth.

Germany is likely to dominate the European vascular stent market growth over the forecast period due to the unhealthy lifestyle changes, increasing the occurrence rate of cardiovascular situations is driving the market.

Following Germany, UK, France and other European countries are performing well. Favourable reimbursement policies by the government of the European region, particularly in the UK and Germany has increased the acquisition of the stents importantly. However, due to strict regulations by the governmental policies, and growing occurrence rate of product failures and recalls, and approvals for the product launches is one crucial factor restraining the vascular stent market growth over the analysis period.

Companies playing a leading role in the European Vascular Stent Market profiled in the report are Medtronic, plc (Ireland), Abbott Laboratories (U.S.), Boston Scientific Corporation (U.S.), BIOTRONIK SE & Co. KG (Germany), B. Braun Melsungen AG (Germany), Terumo Corporation (Japan), STENTYS SA (France), MicroPort Scientific Corporation (China), Meril Life Sciences Pvt. Ltd. (India), Vascular Concepts (India), W. L. Gore and Associates (U.S.), C. R. Bard (U.S.), Endologix, Inc. (U.S.), Lombard Medical Technologies (U.K.), Translumina GmbH (Germany), and JOTEC GmbH (Germany).